Osmotica Pharmaceuticals PLC
F:O1P

Watchlist Manager
Osmotica Pharmaceuticals PLC Logo
Osmotica Pharmaceuticals PLC
F:O1P
Watchlist
Price: 0.003 EUR
Market Cap: 298k EUR

Relative Value

There is not enough data to reliably calculate the relative value of O1P.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

O1P Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
1.1
Industry
2.6
Forward
0
vs History
vs Industry
Median 3Y
-0
Median 5Y
-0.7
Industry
21.6
Forward
-0
vs History
vs Industry
Median 3Y
-0
Median 5Y
-0
Industry
16.5
vs History
vs Industry
Median 3Y
-0
Median 5Y
-0.3
Industry
22.5
vs History
vs Industry
Median 3Y
0
Median 5Y
1.5
Industry
2.3
vs History
vs Industry
Median 3Y
-0.1
Median 5Y
1
Industry
2.9
Forward
-0.1
vs History
vs Industry
Median 3Y
-0.2
Median 5Y
1.8
Industry
5.5
vs History
vs Industry
Median 3Y
0.1
Median 5Y
0.1
Industry
13
vs History
vs Industry
Median 3Y
0.1
Median 5Y
0.1
Industry
16.6
vs History
vs Industry
Median 3Y
0.2
Median 5Y
0.2
Industry
15.8
vs History
vs Industry
Median 3Y
0.2
Median 5Y
0.2
Industry
19.1
vs History
vs Industry
Median 3Y
-0.1
Median 5Y
0.8
Industry
1.9

Multiples Across Competitors

O1P Competitors Multiples
Osmotica Pharmaceuticals PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Osmotica Pharmaceuticals PLC
F:O1P
298k EUR 0 -0 0.1 0.1
US
Eli Lilly and Co
NYSE:LLY
997.2B USD 16.8 54.2 36.3 39
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
503.6B USD 5.5 20 16.4 21.3
CH
Roche Holding AG
SIX:ROG
252.5B CHF 4.1 26.8 11.5 13.4
UK
AstraZeneca PLC
LSE:AZN
211.1B GBP 4.9 30.2 108.7 159.1
CH
Novartis AG
SIX:NOVN
205.8B CHF 4.6 18 11.4 14.7
US
Merck & Co Inc
NYSE:MRK
244.4B USD 3.8 12.8 9.2 10.9
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.3 13.1 9.1 10.6
IE
Endo International PLC
LSE:0Y5F
209B USD 90.1 -71.5 331.1 830.4
US
Pfizer Inc
NYSE:PFE
145.2B USD 2.3 14.8 7.5 10.3
P/E Multiple
Earnings Growth PEG
US
Osmotica Pharmaceuticals PLC
F:O1P
Average P/E: 23.7
Negative Multiple: -0
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
54.2
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
20
29%
0.7
CH
Roche Holding AG
SIX:ROG
26.8
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
30.2
38%
0.8
CH
Novartis AG
SIX:NOVN
18
17%
1.1
US
Merck & Co Inc
NYSE:MRK
12.8
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.1
4%
3.3
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -71.5 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.8
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Osmotica Pharmaceuticals PLC
F:O1P
Average EV/EBITDA: 398.9
0.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
36.3
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.4
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.5
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
108.7
10%
10.9
CH
Novartis AG
SIX:NOVN
11.4
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.2
6%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
9.1
2%
4.6
IE
E
Endo International PLC
LSE:0Y5F
331.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
1%
7.5
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Osmotica Pharmaceuticals PLC
F:O1P
Average EV/EBIT: 1 710.2
0.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.3
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.4
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
159.1
23%
6.9
CH
Novartis AG
SIX:NOVN
14.7
12%
1.2
US
Merck & Co Inc
NYSE:MRK
10.9
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
10.6
1%
10.6
IE
E
Endo International PLC
LSE:0Y5F
830.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.3
8%
1.3